Anavex Life Sciences Corp.
Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease
Last updated:
Abstract:
Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
Status:
Grant
Type:
Utility
Filling date:
14 Jun 2017
Issue date:
1 Oct 2019